Science Explorer Back to mapMap
Discussion
Researcher · Charles University · Czechia

Marek Trněný

Marek Trněný publishes mostly in Pathology and Forensic Medicine, Genetics and Oncology, on topics such as Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research and CAR-T cell therapy research.

ORCID 0000-0002-6952-6073 OpenAlex
World rank
#546,923
of 7,710,434 ranked researchers
Rank in Czechia
#836
of 39,303
Works
763
Citations
27k
Citations per work
35.4
h-index
68
i10-index 232Top 1.9% in Pathology and Forensic Medicine
Marek Trněný

What does Marek Trněný research?

Marek Trněný's work is mostly in Medicine (69%), Immunology and Microbiology (6%).

Health Sciences: 527 works · 69.1% of their workMedicine: 527 works · 69.1% of their workPathology and Forensic Medicine: 212 works · 27.8% of their workGenetics: 125 works · 16.4% of their workOncology: 111 works · 14.6% of their workHematology: 40 works · 5.2% of their workNeurology: 39 works · 5.1% of their workEverything else: 193 works · 25.3% of their workLife Sciences: 43 works · 5.6% of their workImmunology and Microbiology: 43 works · 5.6% of their workImmunology: 43 works · 5.6% of their workTHEIR WORKMarek Trněný763works
Life Sciences6%Health Sciences69%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine52769.1%
  2. Everything else19325.3%
    1. Immunology and Microbiology435.6%
  1. 1Pathology and Forensic Medicine28% of their works
  2. 2Genetics16% of their works
  3. 3Oncology15% of their works
  4. 4Immunology6% of their works
  5. 5Hematology5% of their works
  6. 6Neurology5% of their works

Research topics

Which keywords describe Marek Trněný's research?

The keywords of their largest research topics: Rituximab, Lymphoma, Classification, Molecular Profiling, Prognostic Factors, Chronic Lymphocytic Leukemia, Genomic Aberrations and CAR T Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 19 words, with their numbers
  1. Rituximab8162 topics
  2. Lymphoma6442 topics
  3. Classification5151 topic
  4. Molecular Profiling5151 topic
  5. Prognostic Factors4093 topics
  6. Chronic Lymphocytic Leukemia3011 topic
  7. Genomic Aberrations3011 topic
  8. CAR T Cells1291 topic
  9. Chimeric Antigen Receptor1291 topic
  10. Primary CNS Lymphoma911 topic
  11. Prognostic Scoring System911 topic
  12. Epstein-Barr Virus701 topic
  13. Kaposi's Sarcoma701 topic
  14. Acute Lymphoblastic Leukemia561 topic
  15. Childhood Cancer561 topic
  16. Fc Receptors541 topic
  17. Therapeutic Antibodies541 topic
  18. Cutaneous Lymphomas521 topic
  19. Mycosis Fungoides521 topic

Where does Marek Trněný work?

Marek Trněný's main affiliation in the publication record is Charles University, Czechia.

How many publications and citations does Marek Trněný have?

OpenAlex counts 763 works and 26,981 citations for Marek Trněný, an h-index of 68, ranking #546,923 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Marek Trněný. Posts are plain text and can be reported.